{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:36:40Z","timestamp":1791607000070,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.humpath.2023.01.008","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T21:19:16Z","timestamp":1675372756000},"page":"99-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Cribriform pattern and intraductal carcinoma of the prostate can have a clinicopathological impact, regardless of their percentage and\/or number of cores"],"prefix":"10.1016","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7079-4454","authenticated-orcid":false,"given":"Yoichiro","family":"Okubo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chie","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuyuki","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayoi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Washimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Yokose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Miyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2023.01.008_bib1","first-page":"209","article-title":"Global cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.humpath.2023.01.008_bib2","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.urolonc.2021.05.016","article-title":"A 25 year perspective on advances in the pathologic assessment and diagnosis of urologic cancers","volume":"39","author":"Hansel","year":"2021","journal-title":"Urol Oncol"},{"key":"10.1016\/j.humpath.2023.01.008_bib3","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.eururo.2022.07.002","article-title":"The 2022 world health organization classification of tumors of the urinary system and male genital organs-Part B: prostate and urinary tract tumors","volume":"82","author":"Netto","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2023.01.008_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154188","article-title":"Significance of non-standardized magnetic resonance imaging abnormalities and subsequent targeted prostate cancer biopsy for pathologists: a retrospective observational study","volume":"240","author":"Okubo","year":"2022","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.humpath.2023.01.008_bib5","first-page":"1118","article-title":"ISUP consensus definition of cribriform pattern prostate cancer","volume":"45","author":"van der Kwast","year":"2021","journal-title":"Am\u00a0J\u00a0Surg\u00a0Pathol"},{"key":"10.1016\/j.humpath.2023.01.008_bib6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41379-018-0157-9","article-title":"Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis","volume":"32","author":"Hollemans","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2023.01.008_bib7","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/his.14658","article-title":"Large and small cribriform architecture have similar adverse clinical outcome on prostate cancer biopsies","volume":"80","author":"Rijstenberg","year":"2022","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2023.01.008_bib8","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/modpathol.3800702","article-title":"Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance","volume":"19","author":"Guo","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2023.01.008_bib9","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/PAS.0000000000001497","article-title":"The 2019 international society of urological pathology (ISUP) consensus conference on grading of prostatic carcinoma","volume":"44","author":"van Leenders","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2023.01.008_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.695251","article-title":"Clinicopathological analysis of the ISUP grade group and other parameters in prostate cancer: elucidation of mutual impact of the various parameters","volume":"11","author":"Okubo","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.humpath.2023.01.008_bib11","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/iju.12657","article-title":"Intraductal carcinoma of the prostate: a comprehensive and updated review","volume":"22","author":"Tsuzuki","year":"2015","journal-title":"Int J Urol"},{"key":"10.1016\/j.humpath.2023.01.008_bib12","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 international society of urological pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2023.01.008_bib13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/his.14216","article-title":"Head to head: should the intraductal component of invasive prostate cancer be graded?","volume":"78","author":"Varma","year":"2021","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2023.01.008_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PAP.0000000000000287","article-title":"Similarities and differences in the 2019 ISUP and GUPS recommendations on prostate cancer grading: a guide for practicing pathologists","volume":"28","author":"Smith","year":"2021","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.humpath.2023.01.008_bib15","doi-asserted-by":"crossref","first-page":"461","DOI":"10.5858\/arpa.2020-0015-RA","article-title":"The 2019 genitourinary pathology society (GUPS) white paper on contemporary grading of prostate cancer","volume":"145","author":"Epstein","year":"2021","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2023.01.008_bib16","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00428-022-03272-0","article-title":"Diagnostic significance of reassessment of prostate biopsy specimens by experienced urological pathologists at a high-volume institution","volume":"480","author":"Okubo","year":"2022","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2023.01.008_bib17","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/modpathol.2016.49","article-title":"Disease-specific survival of patients with invasive cribriform and intraductal prostate cancer at diagnostic biopsy","volume":"29","author":"Kweldam","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2023.01.008_bib18","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-3-319-42740-9_6","article-title":"Intraductal carcinoma of prostate (IDC-P): from obscure to significant","volume":"28","author":"Chen","year":"2016","journal-title":"Chin J Cancer Res"},{"key":"10.1016\/j.humpath.2023.01.008_bib19","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1002\/1097-0142(19861015)58:8<1714::AID-CNCR2820580823>3.0.CO;2-M","article-title":"Cribriform adenocarcinoma of the prostate","volume":"58","author":"McNeal","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2023.01.008_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2021.153731","article-title":"Clinicopathological and genetic analyses of small cell neuroendocrine carcinoma of the prostate: histological features for accurate diagnosis and toward future novel therapies","volume":"229","author":"Ida","year":"2022","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.humpath.2023.01.008_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.676716","article-title":"Tissue-based biomarkers for the risk stratification of men with clinically localized prostate cancer","volume":"11","author":"Basourakos","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.humpath.2023.01.008_bib22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.5152\/dir.2014.14372","article-title":"MRI-guided core needle biopsy of the prostate: acceptance and side effects","volume":"21","author":"Egbers","year":"2015","journal-title":"Diagn Interv Radiol"},{"key":"10.1016\/j.humpath.2023.01.008_bib23","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.eururo.2012.01.050","article-title":"Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades","volume":"61","author":"Epstein","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2023.01.008_bib24","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1056\/NEJMoa1910038","article-title":"MRI-targeted, systematic, and combined biopsy for prostate cancer diagnosis","volume":"382","author":"Ahdoot","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2023.01.008_bib25","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.eururo.2014.11.037","article-title":"Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis","volume":"68","author":"Schoots","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.humpath.2023.01.008_bib26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4111\/icu.2019.60.1.4","article-title":"Magnetic resonance imaging-transrectal ultrasound fusion image-guided prostate biopsy: current status of the cancer detection and the prospects of tailor-made medicine of the prostate cancer","volume":"60","author":"Shoji","year":"2019","journal-title":"Investig Clin Urol"},{"key":"10.1016\/j.humpath.2023.01.008_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14030820","article-title":"Intraductal carcinoma\u00a0of the prostate as a cause of prostate cancer metastasis: a molecular portrait","volume":"14","author":"Pantazopoulos","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.humpath.2023.01.008_bib28","article-title":"Oncological outcomes of cribriform histology pattern in prostate cancer patients: a systematic review and meta-analysis","author":"Russo","year":"2022","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.humpath.2023.01.008_bib29","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1111\/cas.15392","article-title":"Clinical significance of IDC-P as predictive factor after intensity-modulated radiation therapy","volume":"113","author":"Aizawa","year":"2022","journal-title":"Cancer Sci"},{"key":"10.1016\/j.humpath.2023.01.008_bib30","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.humpath.2020.02.004","article-title":"Gleason pattern 4 with cribriform morphology on biopsy is associated with adverse clinicopathological findings in a prospective radical prostatectomy cohort","volume":"98","author":"Haffner","year":"2020","journal-title":"Hum Pathol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817723000278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817723000278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:41:29Z","timestamp":1758645689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817723000278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":30,"alternative-id":["S0046817723000278"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2023.01.008","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cribriform pattern and intraductal carcinoma of the prostate can have a clinicopathological impact, regardless of their percentage and\/or number of cores","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2023.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}